Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;22(10):679-81.
doi: 10.1111/exd.12233.

Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility

Xue Zeng  1 , Haoyan Chen, Rashmi Gupta, Oscar Paz-Altschul, Anne M Bowcock, Wilson Liao
Affiliations

Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility

Xue Zeng et al. Exp Dermatol. 2013 Oct.

Abstract

Psoriasis is an inflammatory, immune-mediated disease of the skin. Several studies have suggested that natural killer (NK) cells and their receptors may be important for its pathogenesis. Here, we examined whether deletion of the activating natural killer receptor gene NKG2C, which has a frequency of 20% in the European population, was associated with psoriasis susceptibility. The NKG2C deletion and a functional polymorphism in its ligand HLA-E were genotyped in a Caucasian cohort of 611 psoriasis cases and 493 controls. We found that the NKG2C deletion was significantly increased in cases compared with controls [0.258 vs 0.200, P = 0.0012, OR = 1.43 (1.15-1.79)]. The low-expressing HLA-E*01:01 allele was associated with psoriasis (P = 0.0018), although this association was dependent on HLA-C. Our findings support a potential immunoregulatory role for NK cells in psoriasis and suggest the importance of future studies to investigate the contribution of NK cells and their regulatory receptors to the pathogenesis of psoriasis.

Keywords: HLA-E; KLRC2; NKG2C; natural killer; psoriasis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

No conflicts of interest to disclose.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nestle FO, Kaplan DH, Barker J. Psoriasis. The New England journal of medicine. 2009;361:496–509. - PubMed
    1. Fujiwara S, Nagai H, Oniki S, Yoshimoto T, Nishigori C. Interleukin (IL)-17 versus IL- 27: opposite effects on tumor necrosis factor-alpha-mediated chemokine production in human keratinocytes. Experimental dermatology. 2012;21:70–72. - PubMed
    1. Dunphy S, Gardiner CM. NK cells and psoriasis. Journal of biomedicine & biotechnology. 2011;2011:248317. - PMC - PubMed
    1. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A. CD56brightCD16(−) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. European journal of immunology. 2006;36:118–128. - PubMed
    1. Holm SJ, Sakuraba K, Mallbris L, Wolk K, Stahle M, Sanchez FO. Distinct HLA-C/ KIR genotype profile associates with guttate psoriasis. The Journal of investigative dermatology. 2005;125:721–730. - PubMed

Publication types

Substances